Consensus statement for diagnosis of subcortical small vessel disease

[1]  Wiesje M. van der Flier,et al.  Vascular cognitive impairment , 2018, Nature Reviews Disease Primers.

[2]  X. Tong,et al.  Simvastatin Restored Vascular Reactivity, Endothelial Function and Reduced String Vessel Pathology in a Mouse Model of Cerebrovascular Disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  H. Chui,et al.  Clinical and imaging features of mixed Alzheimer and vascular pathologies , 2015, Alzheimer's Research & Therapy.

[4]  Jeffrey F. Thompson,et al.  Hypoxia-Induced Neuroinflammatory White-Matter Injury Reduced by Minocycline in SHR/SP , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  A. Bonev,et al.  Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease , 2015, Proceedings of the National Academy of Sciences.

[6]  Erik B. Erhardt,et al.  Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  Arthur W. Toga,et al.  Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.

[8]  D. Werring,et al.  White Matter Changes in Dementia: Role of Impaired Drainage of Interstitial Fluid , 2015, Brain pathology.

[9]  C. Sudlow,et al.  Enlarged perivascular spaces and cerebral small vessel disease , 2013, International journal of stroke : official journal of the International Stroke Society.

[10]  Ann D. Cohen,et al.  Early detection of Alzheimer's disease using PiB and FDG PET , 2014, Neurobiology of Disease.

[11]  Kristine Yaffe,et al.  Connections between sleep and cognition in older adults , 2014, The Lancet Neurology.

[12]  M. Viitanen,et al.  CADASIL and CARASIL , 2014, Brain pathology.

[13]  A. Thiel,et al.  Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke. , 2014, Stroke.

[14]  C. Torborg,et al.  Recommendations of the Alzheimer's Disease–Related Dementias Conference , 2014, Neurology.

[15]  N. Bornstein,et al.  Cognitive State following Stroke: The Predominant Role of Preexisting White Matter Lesions , 2014, PloS one.

[16]  M. Schocke,et al.  Changes in White Matter Integrity before Conversion from Mild Cognitive Impairment to Alzheimer’s Disease , 2014, PloS one.

[17]  Owen Carmichael,et al.  White Matter Hyperintensities and Their Penumbra Lie Along a Continuum of Injury in the Aging Brain , 2014, Stroke.

[18]  A. Wallin,et al.  Multimodal Markers of Inflammation in the Subcortical Ischemic Vascular Disease Type of Vascular Cognitive Impairment , 2014, Stroke.

[19]  F. Faraci,et al.  Cerebral small vessel disease: insights and opportunities from mouse models of collagen IV-related small vessel disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. , 2014, Stroke.

[20]  Jae Seung Kim,et al.  Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment. , 2014, JAMA psychiatry.

[21]  Jeffrey F. Thompson,et al.  Tissue Oxygen is Reduced in White Matter of Spontaneously Hypertensive-Stroke Prone Rats: A Longitudinal Study with Electron Paramagnetic Resonance , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  M. Dichgans,et al.  Dilated Perivascular Spaces in Small-Vessel Disease: A Study in CADASIL , 2014, Cerebrovascular Diseases.

[23]  M. Macleod,et al.  Systematic Review and Meta-Analysis of Interventions Tested in Animal Models of Lacunar Stroke , 2014, Stroke.

[24]  Benjamin S Aribisala,et al.  Circulating Inflammatory Markers Are Associated With Magnetic Resonance Imaging-Visible Perivascular Spaces But Not Directly With White Matter Hyperintensities , 2014, Stroke.

[25]  G. Semenza,et al.  Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. , 2014, Annual review of pathology.

[26]  J. Baron,et al.  White matter perivascular spaces , 2014, Neurology.

[27]  D. Werring,et al.  Outcome markers for clinical trials in cerebral amyloid angiopathy , 2001, The Lancet Neurology.

[28]  J. Griffin,et al.  Activated Protein C Analog Protects From Ischemic Stroke and Extends the Therapeutic Window of Tissue-Type Plasminogen Activator in Aged Female Mice and Hypertensive Rats , 2013, Stroke.

[29]  C. Iadecola,et al.  The Pathobiology of Vascular Dementia , 2013, Neuron.

[30]  L. Wolfson,et al.  Rapid buildup of brain white matter hyperintensities over 4 years linked to ambulatory blood pressure, mobility, cognition, and depression in old persons. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  C. Iadecola,et al.  Hypertension: A Harbinger of Stroke and Dementia , 2013, Hypertension.

[32]  S. Ropele,et al.  Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. , 2013, Brain : a journal of neurology.

[33]  J. Trojanowski,et al.  Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. , 2013, Brain : a journal of neurology.

[34]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[35]  Gunhild Waldemar,et al.  Deterioration of Gait and Balance over Time: The Effects of Age-Related White Matter Change - The LADIS Study , 2013, Cerebrovascular Diseases.

[36]  A. Joutel,et al.  Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. , 2013, Brain : a journal of neurology.

[37]  Florindo Stella,et al.  White matter abnormalities associated with Alzheimer’s disease and mild cognitive impairment: a critical review of MRI studies , 2013, Expert review of neurotherapeutics.

[38]  P. Scheltens,et al.  Diffusion changes predict cognitive and functional outcome: The LADIS study , 2013, Annals of neurology.

[39]  Anand Viswanathan,et al.  Topography of dilated perivascular spaces in subjects from a memory clinic cohort , 2013, Neurology.

[40]  Richard W. Bohannon,et al.  INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY). , 2013, American heart journal.

[41]  Eric Westman,et al.  Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD , 2013, Scientific Reports.

[42]  Saeid Taheri,et al.  1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[43]  Kirsten Shuler,et al.  Blood–Brain Barrier Permeability and Long-Term Clinical and Imaging Outcomes in Cerebral Small Vessel Disease , 2013, Stroke.

[44]  M. Schocke,et al.  Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[45]  P. Scheltens,et al.  Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS study , 2013, Journal of Neurology.

[46]  E. Candelario-Jalil,et al.  Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke , 2013, Molecular Brain.

[47]  V. Hachinski,et al.  Antihypertensive treatment can prevent stroke and cognitive decline , 2012, Nature Reviews Neurology.

[48]  Evan Fletcher,et al.  Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study , 2012, The Lancet Neurology.

[49]  C. Jack,et al.  A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology. , 2012, Journal of neuropathology and experimental neurology.

[50]  A. Hainsworth,et al.  Pre-clinical models of human cerebral small vessel disease: Utility for clinical application , 2012, Journal of the Neurological Sciences.

[51]  J. Attems,et al.  Vascular dementia: Different forms of vessel disorders contribute to the development of dementia in the elderly brain , 2012, Experimental Gerontology.

[52]  W. M. van der Flier,et al.  White Matter Lesion Progression in LADIS: Frequency, Clinical Effects, and Sample Size Calculations , 2012, Stroke.

[53]  K. Blennow,et al.  Low Cerebrospinal Fluid Sulfatide Predicts Progression of White Matter Lesions – The LADIS Study , 2012, Dementia and Geriatric Cognitive Disorders.

[54]  Gary A Rosenberg,et al.  Neurological Diseases in Relation to the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  Berislav V. Zlokovic,et al.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.

[56]  Jeffrey F. Thompson,et al.  Myelin Loss Associated With Neuroinflammation in Hypertensive Rats , 2012, Stroke.

[57]  B. Mazoyer,et al.  Circulating IL-6 and CRP are associated with MRI findings in the elderly , 2012, Neurology.

[58]  Eric E. Smith,et al.  Cerebral microinfarcts: the invisible lesions , 2012, The Lancet Neurology.

[59]  Amos D. Korczyn,et al.  Vascular dementia , 1993, Journal of the Neurological Sciences.

[60]  北村 彰浩.  Selective white matter abnormalities in a novel rat model of vascular dementia , 2012 .

[61]  H. Tomimoto.  Subcortical vascular dementia , 2011, Neuroscience Research.

[62]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[63]  C. Jack,et al.  Ecology of the aging human brain. , 2011, Archives of neurology.

[64]  Clifford Qualls,et al.  Blood–Brain Barrier Permeability Abnormalities in Vascular Cognitive Impairment , 2011, Stroke.

[65]  Owen Carmichael,et al.  White Matter Hyperintensity Penumbra , 2011, Stroke.

[66]  A. Dorrance,et al.  Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension. , 2011, American journal of hypertension.

[67]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[68]  Jeffrey F. Thompson,et al.  Matrix Metalloproteinases Are Associated With Increased Blood–Brain Barrier Opening in Vascular Cognitive Impairment , 2011, Stroke.

[69]  Saeid Taheri,et al.  Quantitative measurement of blood‐brain barrier permeability in human using dynamic contrast‐enhanced MRI with fast T1 mapping , 2011, Magnetic resonance in medicine.

[70]  M. Moskowitz,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression , 2011, Annals of neurology.

[71]  A. Joutel.  Pathogenesis of CADASIL , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[72]  A. Alexander,et al.  Diffusion tensor imaging of the brain , 2007, Neurotherapeutics.

[73]  K. Blennow,et al.  Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[74]  L. Grinberg,et al.  Toward a pathological definition of vascular dementia , 2010, Journal of the Neurological Sciences.

[75]  Peter Garrard,et al.  Experimental models of vascular dementia and vascular cognitive impairment: a systematic review , 2010, Journal of neurochemistry.

[76]  J. Hallenbeck.  How inflammation modulates central nervous system vessel activation and provides targets for intervention—a personal perspective , 2010, Annals of the New York Academy of Sciences.

[77]  L. Pantoni.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[78]  C. DeCarli,et al.  Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia: Differential Effects by Hippocampal Size , 2010, Stroke.

[79]  L. Grinberg,et al.  Vascular pathology in the aged human brain , 2010, Acta Neuropathologica.

[80]  A. Schedl,et al.  Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. , 2010, The Journal of clinical investigation.

[81]  F. Howe,et al.  Blood–brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[82]  J. M. Wardlaw,et al.  Blood brain barrier: ageing and microvascular disease-systematic review and meta-analysis , 2009, Journal of the Neurological Sciences.

[83]  João Ricardo Sato,et al.  Improved detection of incipient vascular changes by a biotechnological platform combining post mortem MRI in situ with neuropathology , 2009, Journal of the Neurological Sciences.

[84]  M. Dichgans,et al.  CADASIL , 2009, The Lancet Neurology.

[85]  Frederik Barkhof,et al.  Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort , 2009, BMJ : British Medical Journal.

[86]  B. Dunn,et al.  Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. , 2009, Stroke.

[87]  H S Markus,et al.  Cerebrovascular reactivity and dynamic autoregulation in ischaemic subcortical white matter disease , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[88]  F. Howe,et al.  Reduced N‐acetylaspartate is consistent with axonal dysfunction in cerebral small vessel disease , 2009, NMR in biomedicine.

[89]  Joanna M. Wardlaw,et al.  Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis , 2009, Neurobiology of Aging.

[90]  Cathie Sudlow,et al.  Lacunar stroke is associated with diffuse blood–brain barrier dysfunction , 2009, Annals of neurology.

[91]  Jeffrey F. Thompson,et al.  Increased Apparent Diffusion Coefficients on MRI Linked with Matrix Metalloproteinases and Edema in White Matter after Bilateral Carotid Artery Occlusion in Rats , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[92]  G. Rosenberg.  Matrix metalloproteinases and their multiple roles in neurodegenerative diseases , 2009, The Lancet Neurology.

[93]  M. Goedert.  Oskar Fischer and the study of dementia , 2008, Brain : a journal of neurology.

[94]  Yong Yan,et al.  Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion , 2008, Neuroscience bulletin.

[95]  F. Howe,et al.  Diffusion tensor imaging and MR spectroscopy in hypertension and presumed cerebral small vessel disease , 2008, Magnetic resonance in medicine.

[96]  A. Takanohashi,et al.  Mucosal Tolerization to E-Selectin Protects against Memory Dysfunction and White Matter Damage in a Vascular Cognitive Impairment Model , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[97]  A. Wallin,et al.  Vascular Dementia Nosology – Concepts and Evidence , 2008 .

[98]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[99]  M. Rovaris,et al.  Serial Whole-Brain N-Acetylaspartate Concentration in Healthy Young Adults , 2007, American Journal of Neuroradiology.

[100]  A. Dorrance,et al.  Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats. , 2007, Microvascular research.

[101]  F. Bari,et al.  Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseases , 2007, Brain Research Reviews.

[102]  Jeffrey F. Thompson,et al.  Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in Rat , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[103]  RyosukeTakahashi,et al.  Matrix Metalloproteinase-2 Plays a Critical Role in the Pathogenesis of White Matter Lesions After Chronic Cerebral Hypoperfusion in Rodents , 2006 .

[104]  S. Black,et al.  National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards , 2006, Stroke.

[105]  L. Fan,et al.  Minocycline attenuates hypoxia–ischemia‐induced neurological dysfunction and brain injury in the juvenile rat , 2006, The European journal of neuroscience.

[106]  Wang Min,et al.  Leuko araiosis , 2006 .

[107]  C. Brayne,et al.  Population-based neuropathological studies of dementia: design, methods and areas of investigation – a systematic review , 2006, BMC neurology.

[108]  V. Yong,et al.  Metalloproteinases: Mediators of Pathology and Regeneration in the CNS , 2005, Nature Reviews Neuroscience.

[109]  C. Enzinger,et al.  Markers of Endothelial and Hemostatic Activation and Progression of Cerebral White Matter Hyperintensities: Longitudinal Results of the Austrian Stroke Prevention Study , 2005, Stroke.

[110]  Tan Xiao-mei,et al.  CADASIL , 2005 .

[111]  Elena Tremoli,et al.  Analysis of pathological events at the onset of brain damage in stroke‐prone rats: A proteomics and magnetic resonance imaging approach , 2004, Journal of neuroscience research.

[112]  P. Scheltens,et al.  White matter lesion progression , 2004, Neurology.

[113]  J. Adair,et al.  Measurement of Gelatinase B (MMP-9) in the Cerebrospinal Fluid of Patients With Vascular Dementia and Alzheimer Disease , 2004, Stroke.

[114]  Timo Kurki,et al.  Positron Emission Tomography Examination of Cerebral Blood Flow and Glucose Metabolism in Young CADASIL Patients , 2004, Stroke.

[115]  H. Feldman,et al.  Emerging Therapies for Vascular Dementia and Vascular Cognitive Impairment , 2004, Stroke.

[116]  Lian Li,et al.  Patlak plots of Gd‐DTPA MRI data yield blood–brain transfer constants concordant with those of 14C‐sucrose in areas of blood–brain opening , 2003, Magnetic resonance in medicine.

[117]  Christian Enzinger,et al.  Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study , 2003, The Lancet.

[118]  A. Hofman,et al.  Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.

[119]  Hugh S Markus,et al.  Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. , 2003, Brain : a journal of neurology.

[120]  H. Chui,et al.  Subcortical ischaemic vascular dementia , 2002, The Lancet Neurology.

[121]  Kimihiko Abe,et al.  Increased Blood-Brain Barrier Permeability in White Matter Lesions of Binswanger’s Disease Evaluated by Contrast-Enhanced MRI , 2002, Dementia and Geriatric Cognitive Disorders.

[122]  M. Trojano,et al.  Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis , 2002, Multiple sclerosis.

[123]  G. Román.  On the History of Lacunes, Etat criblé, and the White Matter Lesions of Vascular Dementia , 2002, Cerebrovascular Diseases.

[124]  M. Ueno,et al.  Blood–Brain Barrier Disruption in White Matter Lesions in a Rat Model of Chronic Cerebral Hypoperfusion , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[125]  H. Chabriat,et al.  Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis , 2001, The Lancet.

[126]  M. Dichgans,et al.  Reduced Cerebrovascular CO2 Reactivity in CADASIL: A Transcranial Doppler Sonography Study , 2001, Stroke.

[127]  D. Le Bihan,et al.  Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. , 2000, Stroke.

[128]  Zsuzsanna Nagy,et al.  Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease , 1999, The Lancet.

[129]  W. Brooks,et al.  1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly. , 1997, Stroke.

[130]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[131]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[132]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[133]  P. Tofts.  Optimal detection of blood-brain barrier defects with Gd-DTPA MRI-the influences of delayed imaging and optimised repetition time. , 1996, Magnetic resonance imaging.

[134]  J. Kimura,et al.  Protective effect of cyclosporin A on white matter changes in the rat brain after chronic cerebral hypoperfusion. , 1995, Stroke.

[135]  V. Challa,et al.  Periventricular venous collagenosis: association with leukoaraiosis. , 1995, Radiology.

[136]  V. C. Hachinski,et al.  Vascular dementia , 1993, Neurology.

[137]  R. Mayeux,et al.  Clinical determinants of dememtia related to stroke , 1993, Annals of neurology.

[138]  George Fein,et al.  Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities , 1992, Magnetic resonance in medicine.

[139]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[140]  D. Bennett,et al.  Clinical diagnosis of Binswanger's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[141]  K. Blennow,et al.  Blood brain barrier function in vascular dementia , 1990, Acta neurologica Scandinavica.

[142]  K. Haaland,et al.  Clinical significance of MRI white matter lesions in the elderly , 1989, Neurology.

[143]  Fisher Cm,et al.  Binswanger's encephalopathy: a review , 1989 .

[144]  G. Román,et al.  Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. , 1987, JAMA.

[145]  V. Babikian,et al.  Binswanger's disease: a review. , 1987, Stroke.

[146]  R F Spetzler,et al.  Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. , 1986, Stroke.

[147]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[148]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[149]  C. Fisher.  Lacunar strokes and infarcts , 1982, Neurology.

[150]  Luc Crevits,et al.  Pathogenesis of Binswanger chronic progressive subcortical encephalopathy , 1980, Neurology.

[151]  L. Caplan,et al.  Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease) , 1978, Neurology.

[152]  S. Gordon,et al.  Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[153]  H. Handa,et al.  Pathogenetic Similarity of Strokes in Stroke‐Prone Spontaneously Hypertensive Rats and Humans , 1976, Stroke.

[154]  N. Lassen,et al.  Multi-infarct dementia. A cause of mental deterioration in the elderly. , 1974, Lancet.

[155]  J. De Reuck.  The human periventricular arterial blood supply and the anatomy of cerebral infarctions. , 1971, European neurology.

[156]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[157]  I. Feigin,et al.  NEUROPATHOLOGICAL CHANGES LATE IN CEREBRAL EDEMA: THE RELATIONSHIP TO TRAUMA, HYPERTENSIVE DISEASE AND BINSWANGER'S ENCEPHALOPATHY , 1963, Journal of neuropathology and experimental neurology.

[158]  J. Olszewski.  Subcortical arteriosclerotic encephalopathy. Review of the literature on the so-called Binswanger's disease and presentation of two cases. , 1962, World neurology.

[159]  C. Iadecola,et al.  A Harbinger of Stroke and Dementia , 2022 .